It is recommended to monitor blood pressure, especially at the beginning of treatment, due to the general risk of postural hypotension associated with dopaminergic therapy.
Dopaminergilise raviga seostatud üldise posturaalse hüpotensiooni ohu tõttu on eriti ravi alustamisel soovitatav kontrollida vererõhku.